SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BAL PHARMA

BSE: 524824 29 Jun 2025
Healthcare
₹ 99
Bal Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

BAL PHARMA - Share Price & Details

Market Cap
₹158.0
High /Low
158.0 / 76.3
Stock P/E
21.9
Book Value
₹48.6
Dividend Yield
1.21
ROCE
10.1
ROE
₹9.84
Face Value
10.0
PEG Ratio
1.05
EVEBITDA
₹9.47
Debt
150
CMP / FCF
-168.0
Debt to equity
₹1.94
NP Ann
7.24
High price all time
168.0
Piotroski score
₹4.0
Graham Number
70.4
No. Eq. Shares
1.59
Net CF
₹-2.44
Net profit
7.24
Price to book value
2.04
Interest Coverage
₹1.31
Low price all time
13.2
Industry PE
32.0
Reserves
₹61.5
Free Cash Flow
₹1.53

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
BAL PHARMA LTD.NANANANA158.021.9
BDH INDUSTRIES LTD.NANANANA15116.3
Lotus Eye Hospital And InstituNANANANA148203.0

Peer Comparison Chart


About BAL PHARMA

Bal Pharma Ltd., with Security Code 524824, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Has Bal Pharma declared dividend?

(07 Jun 2025)
Bal Pharma Ltd has declared a 12% dividend, with an ex-date of September 17, 2024. While recent total returns have shown volatility, the company has...
Read more →

Bal Pharma Reports Significant Declines in Profitability and Sales for March 2025

(30 May 2025)
Bal Pharma has reported its financial results for the quarter ending March 2025, revealing significant declines in key metrics.
Read more →

BOARD OF BAL PHARMA RECOMMENDS FINAL DIVIDEND

(30 May 2025)
Bal Pharma announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final...
Read more →

Bal Pharma Faces Bearish Shift Amid Declining Profits and Rising Debt Concerns

(29 May 2025)
Bal Pharma, a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its evaluation due to a bearish shift in...
Read more →

BAL PHARMA TO DECLARE QUARTERLY RESULTS

(17 May 2025)
Bal Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025.
Read more →

Price Volume breakout stocks: These stocks likely to be in focus tomorrow!

(06 Apr 2025)
Indian equity indices closed in the deep red on Friday, weighed by IT stock due to U.S. reciprocal tariff announcement.
Read more →